Product References
Comparison of human recombinant protein coatings and fibroblast-ECM to Matrigel for induced pluripotent stem cell culture and renal podocyte differentiation.
ALTEX
Murphy C,Naderlinger E,Mater A,Kluin RJC,Wilmes A
MA1-104 was used in Immunocytochemistry-immunoflourescence to show that all tested coatings were highly comparable to the animal-derived Matrigel for both hiPSC maintenance and differentiation into renal podocyte-like cells.
Thu Jan 26 00:00:00 UTC 2023
Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis.
BMC medicine
Paw M,Kusiak AA,Nit K,Litewka JJ,Piejko M,Wnuk D,Sarna M,Fic K,Stopa KB,Hammad R,Barczyk-Woznicka O,Cathomen T,Zuba-Surma E,Madeja Z,Ferdek PE,Bobis-Wozowicz S
MA1-104 was used in Immunocytochemistry to provide evidence of superior anti-fibrotic properties of EV-H5 over EV-N or EV-H3.
Tue Oct 31 00:00:00 UTC 2023
Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis.
BMC medicine
Paw M,Kusiak AA,Nit K,Litewka JJ,Piejko M,Wnuk D,Sarna M,Fic K,Stopa KB,Hammad R,Barczyk-Woznicka O,Cathomen T,Zuba-Surma E,Madeja Z,Ferdek PE,Bobis-Wozowicz S
MA1-104 was used in Immunocytochemistry to provide evidence of superior anti-fibrotic properties of EV-H5 over EV-N or EV-H3.
Tue Oct 31 00:00:00 UTC 2023
Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.
Discover oncology
Mukherjee S,Chakraborty S,Basak U,Pati S,Dutta A,Dutta S,Roy D,Banerjee S,Ray A,Sa G,Das T
MA1-104 was used in Immunohistochemistry (Paraffin) to show that during initiation as well as after chemotherapy, when NSCCs are not present in the tumor microenvironment, CSCs, albeit present in low numbers, generate immunosuppressive CD4+CD25+FOXP3+ Treg cells in a contact-independent manner by shedding high levels of immune-suppressive Treg-polarizing cytokine TGFβ, thus escaping immune-elimination and initiating the tumor or causing tumor relapse.
Fri Dec 01 00:00:00 UTC 2023
Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanism.
iScience
Astro V,Ramirez-Calderon G,Pennucci R,Caroli J,Saera-Vila A,Cardona-Londoño K,Forastieri C,Fiacco E,Maksoud F,Alowaysi M,Sogne E,Falqui A,Gonzàlez F,Montserrat N,Battaglioli E,Mattevi A,Adamo A
MA1-104 was used in Flow cytometry/Cell sorting to prove the existence of a divergent scaffolding role of KDM1A splice variants, independent of their enzymatic activity, during hESC differentiation into cardiac cells.
Fri Jul 15 00:00:00 UTC 2022
Establishment of an iPSC cohort from three unrelated 47-XXY Klinefelter Syndrome patients (KAUSTi007-A, KAUSTi007-B, KAUSTi009-A, KAUSTi009-B, KAUSTi010-A, KAUSTi010-B).
Stem cell research
Alowaysi M,Fiacco E,Astro V,Adamo A
MA1-104 was used in Flow Cytometry to describe the derivation of multiple 47-XXY iPSC lines from three unrelated KS patients to study the impact of supernumerary X chromosome during early development.
Tue Dec 01 00:00:00 UTC 2020
Establishment of an iPSC cohort from three unrelated 47-XXY Klinefelter Syndrome patients (KAUSTi007-A, KAUSTi007-B, KAUSTi009-A, KAUSTi009-B, KAUSTi010-A, KAUSTi010-B).
Stem cell research
Alowaysi M,Fiacco E,Astro V,Adamo A
MA1-104 was used in Flow Cytometry to describe the derivation of multiple 47-XXY iPSC lines from three unrelated KS patients to study the impact of supernumerary X chromosome during early development.
Tue Dec 01 00:00:00 UTC 2020
Derivation of two naturally isogenic iPSC lines (KAUSTi006-A and KAUSTi006-B) from a mosaic Klinefelter Syndrome patient (47-XXY/46-XY).
Stem cell research
Fiacco E,Alowaysi M,Astro V,Adamo A
MA1-104 was used in Flow cytometry/Cell sorting to show that using naturally isogenic iPSCs from mosaic Klinefelter Syndrome patients to compare disease and healthy cells carrying a virtually identical genomic background.
Tue Dec 01 00:00:00 UTC 2020
Generation of two iPSC lines (KAUSTi001-A, KAUSTi002-A) from a rare high-grade Klinefelter Syndrome patient (49-XXXXY) carrying a balanced translocation t(4,11) (q35,q23).
Stem cell research
Alowaysi M,Fiacco E,Astro V,Adamo A
MA1-104 was used in Immunocytochemistry to generate two iPSC lines 48-XXXY and 49-XXXXY from a non-mosaic 49-XXXXY KS patient carrying a balanced translocation t(4,11) (q35,q23).
Tue Dec 01 00:00:00 UTC 2020
Establishment of iPSC lines from a high-grade Klinefelter Syndrome patient (49-XXXXY) and two genetically matched healthy relatives (KAUSTi003-A, KAUSTi004-A, KAUSTi004-B, KAUSTi005-A, KAUSTi005-B, KAUSTi005-C).
Stem cell research
Alowaysi M,Fiacco E,Astro V,Adamo A
MA1-104 was used in Immunocytochemistry to derived iPSC lines from a high-grade 49-XXXXY Klinefelter Syndrome and two healthy donors' fibroblasts.
Tue Dec 01 00:00:00 UTC 2020
Generation of iPSC lines (KAUSTi011-A, KAUSTi011-B) from a Saudi patient with epileptic encephalopathy carrying homozygous mutation in the GLP1R gene.
Stem cell research
Alowaysi M,Astro V,Fiacco E,Alzahrani F,Alkuraya FS,Adamo A
MA1-104 was used in Immunocytochemistry to establish two iPSC lines from a patient harbouring a rare homozygous splice site variant in GLP1R for use as a model to study the molecular pathology of GLP1R dysfunction.
Mon Dec 28 00:00:00 UTC 2020
Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.
PloS one
Vosough M,Ravaioli F,Zabulica M,Capri M,Garagnani P,Franceschi C,Piccand J,Kraus MR,Kannisto K,Gramignoli R,Strom SC
MA1-104 was used in Immunocytochemistry to show efficient generation of iPSCs from the elderly may provide a source of cells for the regeneration of tissues and organs with autologous cells as well as cellular models for the study of aging, longevity and age-related diseases.
Fri Feb 14 00:00:00 UTC 2020
Hollow microcarriers for large-scale expansion of anchorage-dependent cells in a stirred bioreactor.
Biotechnology and bioengineering
YekrangSafakar A,Acun A,Choi JW,Song E,Zorlutuna P,Park K
MA1-104 was used in Immunocytochemistry-immunofluorescence to demonstrate the expansion of fibroblasts, NIH/3T3 and the expansion and cardiac differentiation of human induced pluripotent stem cells, along with detailed numerical analysis.
Sun Jul 01 00:00:00 UTC 2018
Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation.
Stem cell reports
Balboa D,Weltner J,Eurola S,Trokovic R,Wartiovaara K,Otonkoski T
MA1-104 was used in immunocytochemistry to demonstrate that dCas9 activator controls human pluripotent stem cell differentiation into endodermal lineages
Tue Sep 08 00:00:00 UTC 2015